Leukemia News

Patients with hematologic malignancies who resided in rural areas had a lower likelihood of death in a hospice facility but higher likelihood of dying in a nursing facility than their urban counterparts, according to study results.

Crystal L. Mackall, MD, believes she has an "unusual pedigree" for someone in her position.

Availability of oral anticancer medications has increased greatly during the past decade, offering patients the convenience of fewer appointments, less travel time and targeted treatment within the comfort of their homes.

Active systemic cancer treatment did not appear associated with increased mortality among patients with cancer and COVID-19, according to study results published in JAMA Network Open.

Risks for severe maternal morbidity and mortality appeared higher among pregnancies complicated by cancer, according to study results in a research letter published in JAMA Oncology.

Vaccinated patients with cancer had significantly higher risks for breakthrough COVID-19 infection, especially those undergoing active cancer care, compared with individuals without cancer, according to a study published in JAMA Oncology.

Adding quizartinib to standard chemotherapy and up to 3 years of continuation therapy extended OS among a subset of older adults with newly diagnosed acute myeloid leukemia, according to results of the phase 3 QuANTUM-First trial.

Time-limited venetoclax, obinutuzumab and ibrutinib or venetoclax plus obinutuzumab prolonged PFS compared with chemoimmunotherapy among fit, previously untreated patients with chronic lymphocytic leukemia, according to study results.

Older, fit patients with acute myeloid leukemia who received decitabine had transplant and survival rates comparable to those treated with induction chemotherapy but with fewer toxicities, according to results of a randomized phase 3 study.

The addition of bortezomib to chemotherapy significantly improved survival outcomes among children and young adults with T-cell lymphoblastic lymphoma, according to phase 3 study results published in Journal of Clinical Oncology.